Ad Alert

NAD advises Synaptol to change advertising

Ad Alert

NAD advises Synaptol to change advertising

The The National Advertising Division (NAD) is the advertising industry’s self-regulatory body administered by the Council of Better Business Bureaus., the investigative unit of the advertising industry’s system of self-regulation, is advising Hello Life, LLC, to halt advertising Synaptol as a treatment for ADD and ADHD:

The National Advertising Division has recommended that Hello Life, LLC, discontinue unsupported claims that its Synaptol, a homeopathic remedy, treats or relieves symptoms of Attention Deficit Disorder or Attention Deficit/Hyperactivity Disorder (ADD/ADHD).

NAD further recommended that the advertiser discontinue its use of testimonials claiming that Synaptol treats ADD/ADHD symptoms or that is can be used as a replacement for or alternative to prescription treatments for ADD/ADHD.

Hello Life responded to the NAD, and voluntarily pulled a number of their claims about Synaptol, though not all. Read the full press release here.


You Might Be Interested In

Kratom NC

Ad Alert

Kratom NC

FDA continues crackdown on kratom sellers marketing products with unproven health claims.

Androzene

Ad Alert

Androzene

The science behind this male enhancement supplement is far from rockhard.